Baby-OSCAR reaches the 300th milestone!

Many congratulations to everyone. Baby-OSCAR, the study investigating early targeted treatment of PDA with ibuprofen in extremely preterm babies, recruited its 300th participant. This would not be possible without the strong collaboration of committed neonatologists, skilled echo-cardiographers and amazing nurses working together across the UK.

Particular congratulations to the team at James Cook University Hospital, Middlesbrough who secured this milestone by recruiting twins on 23rd September 2018. Well done team.

We thank all parents for enrolling their babies into the study in support of this important research.

This study is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme (Reference Number 11/92/15). The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.